Physician profile
Robert C Brown
NPI 1932223526
$8,304.57
in general payments reported to CMS, 2019-2025
44 companies · $1,342 in 2025
The $1,342 reported for 2025 was more than what 75% of Urogynecology and Reconstructive Pelvic Surgery (Obstetrics & Gynecology) providers received nationally (typical 2025 total: $413).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $2,602 · 2020: $653 · 2021: $882 · 2022: $900 · 2023: $874 · 2024: $1,052 · 2025: $1,342.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $3,268.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $3,268.16 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Axonics, INC. | $1,860.55 | 2020-2024 | Axonics |
| Intuitive Surgical, INC. | $1,767.23 | 2019-2024 | |
| Abbvie INC. | $1,001.80 | 2019-2025 | Botox |
| Astellas Pharma US INC | $542.82 | 2019-2023 | Veozah, Myrbetriq |
| Boston Scientific Corporation | $481.23 | 2019-2025 | Axonics, Spaceoar Vue System - 10ml |
| Sumitomo Pharma America, INC. | $455.00 | 2023-2025 | Gemtesa, Orgovyx |
| Therapeuticsmd, INC. | $268.63 | 2019-2022 | |
| Pfizer INC. | $251.65 | 2019-2022 | |
| Coloplast Corp | $227.45 | 2019-2025 | |
| Allergan, INC. | $128.12 | 2020-2022 | |
| Immunitybio, INC. | $104.18 | 2025 | |
| Procept Biorobotics Corporation | $88.05 | 2024 | Aquabeam System |
| Scynexis, INC. | $86.27 | 2022 | |
| Janssen Biotech, INC. | $83.83 | 2025 | Erleada |
| Millicent US INC | $75.16 | 2019-2025 | Intrarosa, Femring |
Show all 44 companies
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Robert Brown listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.